SHARE
COPY LINK

COVID-19 STATS

France’s Omicron wave fuels soaring sales of FFP2 masks

Sales of the heavy-duty FFP2 masks have been soaring in France as the highly-contagious Omicron variant of Covid continues to spread.

France's Omicron wave fuels soaring sales of FFP2 masks
A health worker puts on an FFP2 mask. Photo: Fred Dufour/AFP

With more than 300,000 new cases recorded in the last 24-hours by Santé Publique France and the return of the mandatory wearing of masks outdoors in many cities, the French are increasingly adopting the heavy-duty FFP2 mask.

The supermarket chain Carrefour has been selling them since February 2021, but supermarket bosses said weekly sales had jumped from 100,000 to 300,000 in the last few weeks, with 55,000 sold in just one day on January 3rd – the day many French people went back to work.

FFP2 masks, previously recommended only for health workers, offer more efficient protection for both the wearer those around them and also has the advantage of being wearable for up to eight hours in a row – as opposed to surgical masks which are supposed to  be changed every four hours.

However, in addition to being almost five times more expensive than a surgical mask, it requires special precautions. It must be properly fitted and not touched to maintain its potential for optimal protection. Hence, so far, the wearing of FFP2 masks was only recommended for health professionals since they are trained in using them.

The French government, on the other hand, does not specifically advocate one mask over another, and mask rules say only that a mask must fully cover the wearer’s nose and mouth – face shields are not counted as masks.

In a note published on December 8th, he French Conseil Scientifique had only suggested that the FFP2 mask was recommended for “vulnerable or non-vaccinated people” in the individual protection measures in the context of the holidays.

The FFP2 has already been compulsory for a year in Germany and Austria and more recently it has become so in Italy and Greece.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19 VACCINES

IN NUMBERS: One year of Covid vaccinations in France

Monday marks exactly one year since the first Covid vaccination was administered in France - to a 78-year-old lady named Mauricette. Here's a look at what happened next.

Mauricette receives the first Covid vaccination in France
Mauricette receives the first Covid vaccination in France on December 27th 2020. Photo: Thomas Samson/AFP

On December 27th 2020, Mauricette received her Covid vaccination in the greater Paris area and told the assembled reporters Je suis très émue (I am very moved).

One year on, here’s how the French vaccination programme is looking.

77%

Of the total French population are fully vaccinated. Overall 52.7 million have received at least one dose, while 51.6 million are counted as ‘fully vaccinated’.

Until December 22nd, only those aged 12 and over were eligible to be vaccinated, so looking at the eligible population the percentage vaccinated rises to 89 percent fully vaccinated and 91 percent who have received at least one dose.

However there are still 6 million French people who have not been vaccinated.

70-79-years-old

The 70 to 79 age group is the most vaccinated in France, with 98 percent fully vaccinated. However the over-80s age group has a significantly lower vaccination take-up, an unusual pattern not replicated in most European countries.

Just 86 percent of over 80s in France are fully vaccinated, lower than the 70-79 age group (98 percent) and the 60-69, 50-59 and 18-29 age groups, all of which have over 90 percent coverage.

This is of concern to the authorities, as over 80s are likely to be vulnerable to developing the most serious forms of the virus that can result in hospitalisation and death. 

Percentage of the population who have received at least one dose of the vaccine, be region. Map: Covidtracker.fr

40%

While overall vaccine coverage is high, the figures hides wide regional disparities. France’s overseas territories of Martinique and Guadeloupe have only 38 and 39 percent respectively of the population vaccinated, while attempts to introduce the health pass and vaccine mandates for healthcare workers lead to several weeks of violent protests.

Within mainland France, the island of Corsica has the lowest vaccination coverage with just 66.1 percent of the total population having received at least one dose.

Overall the west of France has higher rates than the east, with Brittany the most vaccinated region with 82.5 percent of the population vaccinated, compared to 73.3 percent in the southern Provence-Alpes-Côte d’Azur region.

22 million

The booster shot campaign was launched in France in September, initially reserved for high-risk groups before being expanded by age and then opened up to all adults in November.

Since the beginning of the booster shot campaign the recommended gap between second dose and booster has shortened several times, it is now recommended that people get their booster four months after becoming fully vaccinated (after the second dose for most people).

As of December 26th, 22,002,825 booster doses have been administered in France, according to the Health Ministry.

79%

France has been heavily reliant on Pfizer for its vaccine programme and in total 79 percent of all vaccines administered in France have been Pfizer.

In total four vaccine types are licensed for use in France; Pfizer, Moderna, AstraZeneca and Johnson & Johnson (Janssen).

However only Pfizer is recommended for all uses by French health authorities, as younger people are not advised to have AstraZeneca after reports of rare but severe side effects including blot clots were reported in several European countries. AstraZeneca is still used for older age groups, but there have been issues of supply from AstraZeneca to the EU vaccine procurement programme, which France uses.

Only Pfizer and Moderna are used in the booster shot programme, with Moderna not recommended for under 30s, because of very rare cardiac side effects.

Pfizer is also the only vaccine to have received approval from the European Medicines Agency for use in the 5-11 age group, who have been eligible for a vaccine in France since December 22nd, although Moderna has also submitted an application to the EMA for approval for use on under 12s.

International comparisons

International comparisons should be taken with a pinch of salt, as much depends on having accurate population figures and up-to-date data on the vaccine programme.

However when looking at comparisons for the share of the population that is fully vaccinated or has received at least one dose, France is generally towards the top of league tables with a good level of vaccine coverage.

Opening up vaccinations early to over 12s and more recently to over 5s has also helped France to increase its percentage of the total population vaccinated.

SHOW COMMENTS